The company have substantially improved its development of an innovative treatment for amyloid heart disease, utilizing the investigational drug. Initial patient results suggests promising improvements for patients https://biotech665195.blog-eye.com/42473783/bridgebio-advances-amyloidosis-treatment-using-the-therapy